No definition available.
Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced
PHLEBI_THROMBOP_OTHER_DEEP_VESSE_LOWER_EXTREMITI
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
115 |
4. Check minimum number of eventsNone |
115 |
5. Include endpointsNone |
115 |
6. Filter based on genotype QC (FinnGen only) |
112 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced
based on the number of shared cases.
Similar with more cases:
- DVT of lower extremities
- DVT of lower extremities and pulmonary embolism
- Venous thromboembolism
- Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)
- Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (not available in FinRegistry).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 112 | 63 | 49 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 50.92 | 48.07 | 54.58 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 115
- Matched controls
- 1150
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
+∞
142.4
115
20
B01AA03
ATC
warfarin; systemic
18.2
53.0
87
168
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
20.6
21.3
32
21
B01AB05
ATC
enoxaparin; parenteral
4.5
14.5
66
265
B01AB04
ATC
dalteparin; parenteral
14.8
14.4
24
20
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
14.1
9.7
16
13
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
0
106
0.00
4.28
0.0
4.9
—
32.32
—
0
65
19
72
2.96
3.97
7.2
4.5
1.23
1.22
mmol/l
0.25
14
65
67
452
2.16
3.91
4.4
3.6
0.00
0.00
estimate
-0.00
23
82
66
448
2.11
3.73
4.4
3.6
0.00
0.01
estimate
0.49
27
91
66
448
2.11
3.73
5.3
4.7
0.00
0.00
estimate
-0.00
27
85
44
256
2.16
3.72
5.1
4.0
0.00
0.00
estimate
-0.00
23
81
54
354
1.99
3.22
4.5
3.8
—
—
—
0
0
65
457
1.97
3.15
46.9
15.2
1.54
1.25
inr
1.35
34
129
20
97
2.29
2.56
6.4
3.5
—
—
—
0
0
7
16
4.58
2.51
3.0
2.3
63.43
63.31
%
—
7
16
42
285
1.75
2.07
7.7
3.2
25.89
29.80
u/l
1.26
36
269
54
407
1.62
1.73
7.6
4.3
34.27
35.36
g/l
0.51
47
387
8
32
2.61
1.63
2.8
2.6
92.50
92.66
%
—
8
32
30
199
1.69
1.56
2.1
1.7
624.85
495.31
pmol/l
0.54
20
168
0
44
0.00
1.55
0.0
1.4
—
—
—
0
0
5
15
3.43
1.54
1.0
1.1
—
—
—
0
0
15
80
2.01
1.53
3.1
2.9
57.71
61.07
ml/min/173m2
—
7
28
6
21
2.96
1.52
2.7
1.5
—
—
—
0
0
12
59
2.15
1.49
10.8
6.4
25.05
25.00
mmol/l
0.01
12
59
18
107
1.81
1.35
1.7
1.9
—
—
—
0
0
21
131
1.74
1.35
1.5
1.2
1.13
13.71
u/ml
1.79
12
51
44
335
1.51
1.27
4.2
2.8
—
—
—
0
0
18
110
1.75
1.24
2.1
1.9
—
—
—
0
0
23
153
1.63
1.18
2.0
1.9
—
—
—
0
0
49
388
1.46
1.15
5.1
4.0
37.80
40.01
ng/l
0.04
37
281
12
66
1.91
1.14
2.1
1.6
—
—
—
0
0
46
361
1.46
1.12
2.1
2.1
71.30
77.37
nmol/l
1.06
37
316
5
22
2.33
1.04
2.2
1.5
—
—
—
0
0
0
30
0.00
0.99
0.0
1.2
—
—
—
0
0
0
30
0.00
0.99
0.0
1.2
—
—
—
0
0
6
28
2.20
0.93
3.0
1.6
—
—
—
0
0
6
28
2.20
0.93
2.5
1.6
—
—
—
0
0
6
29
2.13
0.91
1.2
1.2
—
—
—
0
0
0
24
0.00
0.80
0.0
1.5
—
1.82
—
0
5
0
27
0.00
0.78
0.0
1.9
—
—
—
0
0
14
203
0.65
0.76
2.7
2.2
—
—
—
0
0
7
118
0.57
0.72
9.9
7.1
103.71
103.49
mmol/l
—
7
118
5
28
1.82
0.67
9.4
4.2
—
—
—
0
0
24
184
1.38
0.65
2.0
1.8
1362.73
1271.10
nmol/l
0.28
15
141
79
852
0.77
0.59
24.7
14.1
76.79
76.95
ml/min/173m2
0.02
71
687
5
87
0.56
0.59
12.2
3.2
2.58
1.85
mmol/l
—
5
68
79
851
0.77
0.58
4.3
4.2
1.52
1.29
mmol/l
1.60
73
771
6
38
1.61
0.55
1.5
2.3
—
—
—
0
0
16
121
1.37
0.47
1.7
1.5
—
—
—
0
0
8
55
1.49
0.44
1.4
1.6
—
—
—
0
0
5
32
1.59
0.43
11.0
2.7
—
—
—
0
0
0
15
0.00
0.41
0.0
4.4
—
122.87
—
0
15
8
61
1.33
0.40
2.1
2.1
11.28
13.30
nmol/l
—
8
56
0
18
0.00
0.40
0.0
2.2
—
—
—
0
0
84
885
0.81
0.39
4.8
4.7
4.51
4.60
mmol/l
0.34
79
821
8
115
0.67
0.39
6.6
9.2
—
—
—
0
0
16
126
1.31
0.37
1.7
1.3
—
—
—
0
0
30
257
1.23
0.37
2.2
1.7
1.39
1.32
mmol/l
0.20
23
224
57
523
1.18
0.34
14.3
10.2
4.20
3.91
e9/l
0.51
50
457
7
100
0.68
0.32
4.9
5.0
2.84
50.96
ug/l
—
7
86
7
53
1.34
0.31
9.0
8.8
23.81
24.76
mmol/l
—
7
53
95
981
0.82
0.28
35.4
22.4
135.55
134.57
g/l
0.27
95
965
95
981
0.82
0.28
34.7
22.4
41.12
40.10
%
1.29
89
917
87
904
0.85
0.27
5.4
5.3
2.60
2.68
mmol/l
0.33
82
830
11
87
1.29
0.25
5.6
1.9
333.45
394.55
nmol/l
0.66
11
82
5
37
1.37
0.24
1.6
1.9
—
—
—
0
0
14
116
1.24
0.23
12.1
5.0
0.97
1.04
mmol/l
0.44
14
107
5
41
1.23
0.22
1.4
1.0
—
—
—
0
0
17
145
1.20
0.22
1.5
1.3
13.86
37.23
iu/ml
—
7
49
85
880
0.87
0.22
4.6
4.7
1.41
1.49
mmol/l
0.82
80
806
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
52
487
1.12
0.21
2.8
2.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
33
301
1.14
0.20
4.8
3.6
18.40
6.72
mg/mmol
0.38
20
182
21
185
1.17
0.19
4.6
3.4
204.84
114.05
ng/l
0.19
16
147
36
390
0.89
0.19
1.8
2.0
105.16
95.65
pmol/l
0.82
18
192
7
58
1.22
0.18
1.7
1.2
—
—
—
0
0
85
875
0.89
0.16
5.1
4.9
5.92
6.03
mmol/l
0.34
79
805
17
151
1.15
0.14
3.7
2.5
1.12
1.09
e6/l
0.02
11
82
23
251
0.90
0.13
5.2
4.2
23.12
21.80
%
0.18
13
130
21
192
1.11
0.12
1.5
1.2
0.81
0.78
u/ml
0.07
11
55
91
892
1.10
0.10
27.5
15.2
18.97
21.51
mg/l
0.48
82
724
44
460
0.93
0.10
13.3
6.7
1.21
1.21
mmol/l
0.01
27
395
7
68
1.03
0.08
13.4
8.5
26.79
24.75
mmol/l
—
7
63
94
954
0.92
0.08
27.5
17.7
80.47
78.66
umol/l
0.21
94
954
43
414
1.06
0.07
2.3
2.5
—
—
—
0
0
13
118
1.11
0.07
11.4
7.4
12.05
12.14
kpa
0.03
13
113
13
118
1.11
0.07
11.4
7.4
5.58
5.14
kpa
0.46
13
113
87
857
1.06
0.06
6.1
6.2
41.18
40.71
mmol/mol
0.15
82
801
14
138
1.02
0.00
4.2
2.7
1.93
3.44
e6/l
—
8
71
42
425
0.98
0.00
14.5
5.6
1.21
1.21
mmol/l
0.08
35
388
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
4.80
—
0
5
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
11.92
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.4
—
13.96
—
0
7
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (not available in FinRegistry).
Relationships between endpoints
↥Index endpoint: PHLEBI_THROMBOP_OTHER_DEEP_VESSE_LOWER_EXTREMITI – Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced
GWS hits: -
This endpoint is excluded (not available in FinRegistry).